A case of retrobulbar monolateral optic neuritis due to disseminated Cryptococcosis in a 32-year-old man with a new diagnosis of AIDS is described in the era of combination antiretroviral therapy (cART). The patient presented a monolateral rapid visual loss on day 7 of a liposomal amphotericin B treatment. Neuroradiological imaging showed the presence of retrobulbar neuritis. After starting ART and intravenous metilprednisolone 1 g daily for 3 days, we assisted to a progressive improvement of visual acuity. At 3 months of follow-up, complete clinical resolution was obtained. In this case, in the presence of effective antiretroviral and antifungal treatment, a short course of metilprednisolone was a safe therapy.
Introduction
In HIV-infected patients, cryptococcal meningitis is a common opportunistic infection associated with significant morbidity and mortality. Following the introduction of combination antiretroviral therapy (cART), the incidence of cryptococcosis has declined substantially in North America and Western Europe with an incidence per year of 0.04%. 1 In Italy, many patients, called AIDS-presenters, still present this as well as other opportunistic infections at the time of HIV diagnosis.
Here, we describe a case of mono-lateral visual loss, an uncommon complication of cryptococcal meningitis.
Case Report
A previously healthy 32-year-old Caucasian man was admitted to our hospital in August 2009, with a 7-day history of severe frontal headache, photophobia, and mental confusion. The headache was unresponsive to common analgesic treatment. He had been asymptomatic, in his usual state of health until 10 days before, when an accidental slight facial trauma occurred. His past history was not contributory, he did not smoke or use illicit drugs, nor consume alcohol, nor referred sexual intercourse at risk. On examination, the patient presented with fever (his temperature was 38 C), mental confusion, a circular erosive skin lesion with a diameter of about 1 cm covered by red scab on the right temporal-zygomatic area, and palpable lymph nodes in the right axillary area; the liver was palpable at 2 cm below the costal margin. The remainder of the physical examination was normal. Specifically, meningeal signs or focal neurological deficit were not detected.
Routine laboratory tests showed: red blood cells count 4630 Â 10 3 /mL, hemoglobin level 14 g/dL, platelet count 146 Â 10 3 /mL, white blood cells count 4300/mL (with neutrophils 73.3% and lymphocytes 18.1%), erythrocyte sedimentation rate (ERS) 27 mm/h, a2-globulin 10% (total protein 7.2 g/dL), C-reactive protein (CRP) 1.8 mg/dL, urea 29 mg/dL, creatinine 0.75 mg/dL, aspartate aminotransferase 31 mU/mL, alanine aminotransferase 35 mU/mL. A brain computerized tomography and a subsequent magnetic resonance imagining (MRI) examination showed no pathological findings.
Cerebrospinal fluid (CSF) examination showed an opening CSF pressure >60 cm H 2 O, glucose level of 55 mg/dL (blood glucose level of 116 mg/dL), increased protein level (84 mg/dL), 60 cells/mm 3 (90% lymphocytes). CSF microscopic examination by Gram stain showed no bacteria and fungal morphologies and India ink stain revealed the presence of capsulated yeasts. Commercial latex agglutination assay for cryptococcal antigen (CALAS, Meridian Bioscience Europe, Villa Cortese, Milano, Italy) was positive in CSF (with titer of 1:128) and in the serum (with titer of 1:128). CSF culture was positive for Cryptococcus neoformans. HIV serology was positive. At the time of clinical presentation, his HIV serum viral load was 54500 copies/mL and CD4 T lymphocyte count was 20/mm 3 . HIV-RNA in the CSF was 246 000 copies/mL.
Chest radiograph and fundus oculi examination were normal. A culture of facial skin-lesion swab was positive for Cryptococcus neoformans. The patient was treated with liposomal amphotericin B (AmBisome 3.5 mg/kg per day) for 28 days. In addition, serial lumbar punctures were performed for decompressive purpose. On day 5 of liposomal amphotericin B therapy, the opening CSF pressure was 15 cm H 2 O.
On day 7 of therapy, the patient presented rapid visual loss on the left eye. At this time, a fundus oculi examination was repeated and resulted normal, visual on left eye was 4/10, and a campimetric examination showed a large scotoma 10 central on lower nasal area (Figure 1 left panel) . Subsequently, in the next 5 days, he presented ocular pain and severe worsening of visual acuity. He referred only light perception at the left eye. Pupil exam showed: mydriasis, absence of left photo motor reflex, presence of left consensual photo motor reflex. An MRI examination showed bilateral ectasia of the optic nerve sheath, with contrast enhancement around the left optic nerve sheath for its intraorbital course, at postbulbar tract up to prechiasmatic tract. This MRI was compatible with retrobulbar neuritis (Figure 2 left panel) . In the differential diagnosis, we considered other possible causes of retrobulbar optic neuritis that can occur in patient with AIDS, such as infections by Cytomegalovirus, Varicella-zoster virus, and other herpetic viruses. The research for these viruses on the blood by polymerase chain reaction DNA amplification method was negative. We excluded also Treponema pallidum, Borrelia burgdorferi, and Mycobacterium species bacterial infections.
The ART with lopinavir/ritonavir, zidovudine, and lamivudine was started at standard doses, as well a treatment with intravenous (iv) metilprednisolone 1 g iv/daily for 3 days and acyclovir iv at doses of 30 mg/kg daily.
On the second day of metilprednisolone therapy, we observed a decisive improvement of visual acuity, confirmed by serial campimetric examinations (Figure 1 right panel) . Steroid therapy was tolerated without adverse effects. At the time of hospital discharge, the left eye vision was 9/10.
The treatment with amBisome was stopped on 28th day, followed by oral fluconazole. At 3-, 6-, and 12-month follow-up visits, the patient remained well and the visual acuity showed a complete recovery. At the last control HIV-RNA was 24 copies/mL on serum and CD4 T lymphocyte count was 142/mm 
Discussion
In patients with AIDS, visual loss due to cryptococcal meningitis has been estimated to occur in 1.1% to 3.3% of patients. 2, 3 Two different patterns of impaired vision associated with cryptococcosis are known. The first type called ''slow visual loss'' has a subacute course, over weeks or months, and it is linked to papilledema and to intracranial hypertension. In such cases, visual loss is usually bilateral, symmetric, with campimetric defects. Therapeutic measures directed at reducing the intracranial pressure are beneficial. 4 The second pattern, called ''rapid visual loss,'' shows a sudden loss of vision (from 12 hours to a few days after the start of antifungal treatment), and is due to direct invasion of the optic nerve by Cryptococcus.
2 The standard treatment for this second condition is not well-defined. In the present case, the fundus oculii examination was normal, showed no papilledema, and intracranial hypertension was absent. Taken together, these findings are strongly suggestive of optic neuritis diagnosis (rapid visual loss pattern). The visual loss appeared before antiretroviral administration, thus immune reconstitution inflammatory syndrome (IRIS) cannot be advocated. 5 MRI showed monolateral retrobulbar optic neuritis. The evidence supporting optimal therapeutic options are actually limited. In pre-cART era, corticosteroids were considered ineffective. 2 On the other hand, surgical optic nerve fenestration is an invasive procedure considered by some clinicians, 6 that may be reserved for participants not responsive to the medical treatment. In the present case, we considered plausible the direct invasion of the nerve by C neoformans and in accordance with a consultant ophthalmologist, we opted for a short medical treatment using iv metilprednisolone 7 at the dosage of 1 g/day, plus ART and the continuation of antifungal treatment. We ruled out other causes of visual loss in immunocompromised patients, such as Cytomegalovirus, Varicella-zoster virus and Herpes simplex virus infections, by blood investigation of viral genomes and by using acyclovir iv as therapy until obtaining the negative results. In the presence of an effective antiretroviral and antifungal treatment available in the cART era, a short course of glucocorticoids could be considered as a reasonable safe therapy in patients with AIDS having cryptococcal meningitis and monolateral optic neuritis.
